Combining AI and Zebrafish to Accelerate Drug Discovery
As part of our SLAS Europe 2022 coverage, we speak to Dr. Javier Terriente, Co-founder and Chief of Drug Development at ZeClinics, about how zebrafish could be the future for discovering new therapeutics.
Javier Terriente Gorodenkoff Shutterstock Micha Weber Shutterstock Kazakov Maksim Shutterstock Drug Development At Zeclinics Society For Laboratory Automation
Source: news-medical.net